Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Lipid-polymer hybrid nanoparticles show promise for skin treatments but need better formulation strategies.

Fibrosing alopecia starts earlier in Latin American men and often looks like common male pattern baldness.

The study found that treatment improved hair condition in patients with Fibrosing Alopecia in a Pattern Distribution in Chile.

The protein's size was reduced, but more work is needed to confirm its function.

ALUDWIG can help standardize female hair loss assessment from a single image.

Mice with more Flightless I protein grew back their claws better after amputation.

Low-level laser therapy helps male and female hair loss alone or with other treatments.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Frontal fibrosing alopecia is increasingly affecting men, causing hair loss around the hairline and possibly other areas.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Improving medical training is key to eradicating frambusia by 2030.

The two lotions used day and night may be a good alternative to minoxidil for hair loss treatment with better cosmetic effects and tolerance.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

TCF/Lef1 activity is essential for proper skin cell development and renewal.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

A rare skin growth was successfully removed without recurrence after one year.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Lef1 is essential for normal skin, hair growth, and healing wounds in mice.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

A young man was diagnosed with a rare hair loss condition usually seen in older women.

Losing Memo protein shortens lifespan and affects health.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Lichen planus pigmentosus is hard to treat and may be more common in North Africa than previously thought.

Human cells in plasma-derived gels can potentially mimic hair follicle environments, improving hair regeneration therapies.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.

Some skin growths with mucin can form hair follicles and resemble skin cancer, but a special stain can help tell them apart.